QQ客服 官方微博 反馈留言

	Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
	Moayyedi, Paul; Eikelboom, John W.; Bosch, Jackie; Connolly, Stuart J.; Dyal, Leanne; Shestakovska, Olga; Leong, Darryl; Anand, Sonia S.; Stoerk, Stefan; Branch, Kelley R. H.
	2019
卷号	157期号:3页码:682-+
关键词	Reflux Thrombosis CVD Bacteria
ISSN号	0016-5085
DOI	10.1053/j.gastro.2019.05.056
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6340502
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Moayyedi, Paul,Eikelboom, John W.,Bosch, Jackie,et al. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin[J],2019,157(3):682-+.
APA	Moayyedi, Paul.,Eikelboom, John W..,Bosch, Jackie.,Connolly, Stuart J..,Dyal, Leanne.,...&Yusuf, Salim.(2019).Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.,157(3),682-+.
MLA	Moayyedi, Paul,et al."Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin".157.3(2019):682-+.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。